Raynaud's Phenomenon Secondary to Connective Tissue Disease
1 clinical trials · Condition
◉ Watch Raynaud's Phenomenon Secondary to Connective Tissue Disease
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon (NCT02688270) | Covis Pharma S.à.r.l. | 2016-06-01 |
Track Raynaud's Phenomenon Secondary to Connective Tissue Disease automatically
Every clearance here is in the API, with alerts when new ones post.